IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 51 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  Next article
  Previous article 
  Table of Contents
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (249 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
   References
   Article Tables

 Article Access Statistics
    Viewed688    
    Printed47    
    Emailed0    
    PDF Downloaded52    
    Comments [Add]    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 2010  |  Volume : 42  |  Issue : 3  |  Page : 197-198
 

Authors' reply


1 Department of Biochemistry, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana, India
2 Department of Pharmacology, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana, India

Date of Web Publication28-Jul-2010

Correspondence Address:
Richa Vaishya
Department of Biochemistry, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana
India
Login to access the Email id


PMID: 20871778

Get Permissions



How to cite this article:
Vaishya R, Singh J, Lal H. Authors' reply. Indian J Pharmacol 2010;42:197-8

How to cite this URL:
Vaishya R, Singh J, Lal H. Authors' reply. Indian J Pharmacol [serial online] 2010 [cited 2014 Aug 28];42:197-8. Available from: http://www.ijp-online.com/text.asp?2010/42/3/197/66850


Sir,

We thank Dr. Mahajan for his comments [1] on our paper. [2] Our reply to the queries are as follows:

  1. The study was planned to focus the beneficial effects of irbesartan in comparison to insulin and thus the relevance of the study remains clear.
  2. Suggestion at 2 is well-taken for future studies.
  3. We regret the typing error; please read group III for insulin and group IV for irbesartan.
  4. It is a printing error. The original [Table 1] and [Table 3] submitted to the journal office are reproduced here.


 
  References Top

1.Mahajan. Irbesartan in experimental diabetic nephropathy. Indian J Pharmacol 2010;42:197.  Back to cited text no. 1    Medknow Journal  
2.Vaishya R, Singh J, Lal H. Biochemical effects of irbesartan in experimental diabetic nephropathy. Indian J Pharmacol 2009;41:252-4.  Back to cited text no. 2  [PUBMED]  Medknow Journal  



 
 
    Tables

  [Table 1], [Table 3]



 

Top
Print this article  Email this article

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Medknow